Home/Investors/Life Science Angels

Life Science Angels

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 1

Investment Focus

Infectious Disease Respiratory Opioid Use Disorder Neuropathic Pain Neuroinflammation

Portfolio Companies

Company	Stage	Valuation	Focus
Inhalon Biopharma	Phase 1	—	Infectious Disease, Respiratory
Mebias Discovery	Phase 1	—	Opioid Use Disorder, Neuropathic Pain

Frequent Co-Investors

National Institute on Drug Abuse (NIDA)1 shared The Thiel Foundation (Breakout Labs)1 shared JSR Life Sciences1 shared BioAdvance1 shared Viva Biotech (Shanghai) Ltd.1 shared